Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Treating babies with stimulants is reckless

Allen Frances, MD
Meds
May 27, 2014
Share
Tweet
Share

How crazy is it to drug babies?

It was shocking enough to discover that 20% of teenage boys get labelled as having ADHD, and 10% are on stimulant medications for it.  That 11% of all kids aged 4-18 get the diagnosis of ADHD, and 6% the drugs.  That stimulant prescriptions and pharma profits are skyrocketing all around the world.  And that ADHD guidelines encourage making the diagnosis and starting the drugs in kids as young as four.

Then it got worse. An adventurous group of cowboy child psychologists invented a new and untested diagnostic category (with the ridiculous name, “sluggish cognitive tempo'”) that would be a wonderful target for additional inappropriate stimulant use.

It is also particularly outrageous that so many of the thought leaders promoting the excessive use of stimulants have such close ties with pharma. Honor dies where conflict of interest lies. But the latest news tops all in raw shock value. The Centers For Disease Control and Prevention has just estimated that 10,000 U.S. toddlers, aged 2-3, are being given stimulant drugs for behaviors that have been mislabeled as ADHD. This falls outside the already overly inclusive guidelines that start kids at the too early age of four.

Treating babies with stimulants is based on no research, is reckless, and takes no account of the possible harmful long-term effects of bathing baby brains with powerful neurotransmitter drugs.

Many people thought I was being overly optimistic when recently I predicted that the ADHD fad had finally peaked and that we would gradually return to more appropriate levels of diagnosis (perhaps the previous 3% instead of the current 11%). My optimistic prediction was not based on naivete about pharma greed or physician carelessness. My hopes rested on the possibility that there would be a backlash of parental and professional protest as it becomes clearer and clearer how absurdly overused is the ADHD diagnosis and the stimulant medication.

The CDC report will certainly fuel that outrage and help stimulate a backlash, but at what price to the babies?

Allen Frances is a psychiatrist and professor emeritus, Duke University.  He blogs at the Huffington Post.

Prev

Demonizing doctors won't solve our problems

May 27, 2014 Kevin 9
…
Next

A morning in the substance abuse clinic

May 27, 2014 Kevin 3
…

Tagged as: ADHD, Medications, Pediatrics

Post navigation

< Previous Post
Demonizing doctors won't solve our problems
Next Post >
A morning in the substance abuse clinic

ADVERTISEMENT

More by Allen Frances, MD

  • #MeToo shows why women must learn sexual self-defense

    Allen Frances, MD
  • The problem of polypharmacy in psychiatry

    Allen Frances, MD
  • Pay primary care doctors what they’re worth

    Allen Frances, MD

More in Meds

  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Unregulated botanical products: the hidden risks of convenience store supplements

    Muhamad Aly Rifai, MD
  • “The meds made me do it”: Unpacking the Nick Reiner tragedy

    Arthur Lazarus, MD, MBA
  • The dangers of oral steroids for seasonal illness

    Megan Milne, PharmD
  • L-theanine for stress and cognition

    Kamren Hall
  • Most Popular

  • Past Week

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Why insurance must cover home blood pressure monitors

      Soneesh Kothagundla | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
    • The dangers of oral steroids for seasonal illness

      Megan Milne, PharmD | Meds
    • 5 things health care must stop doing to improve physician well-being

      Christie Mulholland, MD | Physician
    • “The meds made me do it”: Unpacking the Nick Reiner tragedy

      Arthur Lazarus, MD, MBA | Meds
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is primary care becoming a triage station?

      J. Leonard Lichtenfeld, MD | Physician
    • Psychiatrists are physicians: a key distinction

      Farid Sabet-Sharghi, MD | Physician
    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
  • Recent Posts

    • Sjogren’s, fibromyalgia, and the weight of invisible illness

      Dr. Bodhibrata Banerjee | Physician
    • When racism findings challenge institutional narratives

      Anonymous | Physician
    • Early detection fails when screening guidelines ignore young women [PODCAST]

      The Podcast by KevinMD | Podcast
    • Student loan cuts for health professionals

      Naa Asheley Ashitey | Policy
    • GLP-1 psychological side effects: a psychiatrist’s view

      Farid Sabet-Sharghi, MD | Conditions
    • Why lab monkey escapes demand transparency

      Mikalah Singer, JD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Why insurance must cover home blood pressure monitors

      Soneesh Kothagundla | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
    • The dangers of oral steroids for seasonal illness

      Megan Milne, PharmD | Meds
    • 5 things health care must stop doing to improve physician well-being

      Christie Mulholland, MD | Physician
    • “The meds made me do it”: Unpacking the Nick Reiner tragedy

      Arthur Lazarus, MD, MBA | Meds
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is primary care becoming a triage station?

      J. Leonard Lichtenfeld, MD | Physician
    • Psychiatrists are physicians: a key distinction

      Farid Sabet-Sharghi, MD | Physician
    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
  • Recent Posts

    • Sjogren’s, fibromyalgia, and the weight of invisible illness

      Dr. Bodhibrata Banerjee | Physician
    • When racism findings challenge institutional narratives

      Anonymous | Physician
    • Early detection fails when screening guidelines ignore young women [PODCAST]

      The Podcast by KevinMD | Podcast
    • Student loan cuts for health professionals

      Naa Asheley Ashitey | Policy
    • GLP-1 psychological side effects: a psychiatrist’s view

      Farid Sabet-Sharghi, MD | Conditions
    • Why lab monkey escapes demand transparency

      Mikalah Singer, JD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Treating babies with stimulants is reckless
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...